EGFR L861R
|
LUAD
|
EGFR L861R
|
LUAD
|
crizotinib Resistant: C4 – Case Studies
|
crizotinib Resistant: C4 – Case Studies
|
EGFR L861R
|
Lung Cancer
|
EGFR L861R
|
Lung Cancer
|
bevacizumab + afatinib Sensitive: C4 – Case Studies
|
bevacizumab + afatinib Sensitive: C4 – Case Studies
|